Friday, July 24, 2026
Advertisement
Home Healthcare Markets Business Sensyne delivers strong revenue growth but warns of short term slowdown

Sensyne delivers strong revenue growth but warns of short term slowdown

Sensyne Health CEO Paul Drayson
Paul Drayson, CEO, Sensyne Health

Clinical AI company Sensyne Health has booked a £7m jump in revenue to £9.1m as new and existing agreements with life science companies delivered strong growth. The company, which raised £27.5m from a placing in January, entered into a number of collaboration agreements in the year to 30 April, including a strategic collaboration with US…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?